Testosterone Triggers Apoptosis in Prostate Cancer Cells
Author Information
Author(s): Papadopoulou Natalia, Charalampopoulos Ioannis, Anagnostopoulou Vasileia, Konstantinidis Georgios, Föller Michael, Gravanis Achilleas, Alevizopoulos Konstantinos, Lang Florian, Stournaras Christos
Primary Institution: Department of Biochemistry, University of Crete Medical School, Heraklion, Greece
Hypothesis
Membrane androgen receptors induce apoptosis in DU145 prostate cancer cells through specific signaling pathways.
Conclusion
Testosterone-albumin conjugates activate specific pro-apoptotic pathways in DU145 prostate cancer cells, suggesting their potential as anti-tumor agents.
Supporting Evidence
- Testosterone-albumin conjugates down-regulated pro-survival pathways in DU145 cells.
- FasL expression was significantly increased following treatment with testosterone-albumin.
- Caspase-3 activity was activated in DU145 cells treated with testosterone-albumin.
- PI-3K and Akt activities were suppressed after testosterone-albumin treatment.
- Actin cytoskeleton disruption inhibited the apoptotic effects of testosterone-albumin.
Takeaway
When prostate cancer cells are treated with a special form of testosterone, they start to die because of changes inside the cells.
Methodology
The study involved treating DU145 prostate cancer cells with testosterone-albumin conjugates and measuring various apoptotic markers and signaling pathways.
Limitations
The study primarily focuses on one cell line and may not represent all prostate cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website